• Immunotherapy in Thymic Epithelial Tumors - 'Risky Business'?

    2 monthes ago - By Medscape

    Pembrolizumab showed encouraging antitumor activity in patients with advanced thymic epithelial tumors, but also a high rate of severe immune-related adverse events.
    Medscape Medical News
    Read more ...